DUTREBIS

Medicinal product

(Invented) name

DUTREBIS

Active substance (s)

Lamivudinas/Raltegraviras

Strength

150 mg/300 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR16, Lamivudine and Raltegravir

Marketing authorisation holder

Merck Sharp & Dohme Ltd., Jungtinė Karalystė

Date of authorisation

2015-03-26

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Plėvele dengtos tabletės	1 vnt.
Lamivudinas	150 mg
Raltegraviras	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61715	76057	1076057	buteliukas	N60		Receptinis	EU/1/15/995/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Išregistruotas
2015-03-26	Registruotas